Literature DB >> 18065174

Determination of intraliposomal pH and its effect on membrane partitioning and passive loading of a hydrophobic camptothecin, DB-67.

Vijay Joguparthi1, Shaoxin Feng, Bradley D Anderson.   

Abstract

The purpose of this work was to study the effect of pH on the liposomal encapsulation of a model camptothecin anti-tumor agent, DB-67, by considering the state of ionization and bilayer membrane/water partitioning of the drug as a function of pH. A novel fluorescence method was developed to monitor intravesicular pH in liposomal formulations containing entrapped DB-67 by using the drug itself as a pH indicator. Fluorescence spectra were recorded in aqueous buffers and liposomes and used to estimate the ionization constant of the A-ring phenol of DB-67 (pKappa(a2)) and shifts in ionization constants ( pKappa (a1) and pKappa(a2) ) due to membrane binding. Bilayer/water partitioning studies by equilibrium dialysis were employed to show that DB-67 is highly membrane bound over the entire pH range examined though binding decreases with an increase in pH. The observed ionization constants of membrane-bound DB-67 obtained from the equilibrium dialysis experiments were consistent with observations from fluorescence measurements and previous permeability results. The pH dependence of DB-67 loading using a passive loading technique was found to reflect the pH dependence of membrane binding of the drug. This results in poor encapsulation efficiency of DB-67 at high pH, necessitating further development of formulation strategies to improve loading efficiency.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18065174      PMCID: PMC2277365          DOI: 10.1016/j.ijpharm.2007.10.003

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  17 in total

1.  Stealth liposomes and tumor targeting: one step further in the quest for the magic bullet.

Authors:  A A Gabizon
Journal:  Clin Cancer Res       Date:  2001-02       Impact factor: 12.531

2.  pH-dependent association of SN-38 with lipid bilayers of a novel liposomal formulation.

Authors:  Viktor Peikov; Sydney Ugwu; Manjeet Parmar; Allen Zhang; Imran Ahmad
Journal:  Int J Pharm       Date:  2005-08-11       Impact factor: 5.875

3.  Liposome transport of hydrophobic drugs: gel phase lipid bilayer permeability and partitioning of the lactone form of a hydrophobic camptothecin, DB-67.

Authors:  Vijay Joguparthi; Tian-Xiang Xiang; Bradley D Anderson
Journal:  J Pharm Sci       Date:  2008-01       Impact factor: 3.534

4.  The accumulation of drugs within large unilamellar vesicles exhibiting a proton gradient: a survey.

Authors:  T D Madden; P R Harrigan; L C Tai; M B Bally; L D Mayer; T E Redelmeier; H C Loughrey; C P Tilcock; L W Reinish; P R Cullis
Journal:  Chem Phys Lipids       Date:  1990-03       Impact factor: 3.329

5.  Effect of solvent-water mixtures on the prototropic equilibria of fluorescein and on the spectral properties of the monoanion

Authors: 
Journal:  Photochem Photobiol       Date:  2000-08       Impact factor: 3.421

6.  Factors influencing uptake and retention of amino-containing drugs in large unilamellar vesicles exhibiting transmembrane pH gradients.

Authors:  E Maurer-Spurej; K F Wong; N Maurer; D B Fenske; P R Cullis
Journal:  Biochim Biophys Acta       Date:  1999-01-12

7.  Development and characterization of a novel liposome-based formulation of SN-38.

Authors:  J Allen Zhang; Tong Xuan; Manjeet Parmar; Lan Ma; Sydney Ugwu; Shahid Ali; Imran Ahmad
Journal:  Int J Pharm       Date:  2004-02-11       Impact factor: 5.875

8.  Liposomal delivery of hydrophobic weak acids: enhancement of drug retention using a high intraliposomal pH.

Authors:  Vijay Joguparthi; Bradley D Anderson
Journal:  J Pharm Sci       Date:  2008-01       Impact factor: 3.534

9.  Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft.

Authors:  F Yuan; M Leunig; S K Huang; D A Berk; D Papahadjopoulos; R K Jain
Journal:  Cancer Res       Date:  1994-07-01       Impact factor: 12.701

10.  The novel highly lipophilic topoisomerase I inhibitor DB67 is effective in the treatment of liver metastases of murine CT-26 colon carcinoma.

Authors:  Lluis A Lopez-Barcons; Junhong Zhang; Gunching Siriwitayawan; Thomas G Burke; Roman Perez-Soler
Journal:  Neoplasia       Date:  2004 Sep-Oct       Impact factor: 5.715

View more
  6 in total

1.  Release, partitioning, and conjugation stability of doxorubicin in polymer micelles determined by mechanistic modeling.

Authors:  Andrei Ponta; Kyle D Fugit; Bradley D Anderson; Younsoo Bae
Journal:  Pharm Res       Date:  2014-11-19       Impact factor: 4.200

2.  Insights into accelerated liposomal release of topotecan in plasma monitored by a non-invasive fluorescence spectroscopic method.

Authors:  Kyle D Fugit; Amar Jyoti; Meenakshi Upreti; Bradley D Anderson
Journal:  J Control Release       Date:  2014-10-25       Impact factor: 9.776

3.  From drug delivery systems to drug release, dissolution, IVIVC, BCS, BDDCS, bioequivalence and biowaivers.

Authors:  Vangelis Karalis; Eleni Magklara; Vinod P Shah; Panos Macheras
Journal:  Pharm Res       Date:  2010-07-16       Impact factor: 4.200

4.  The role of pH and ring-opening hydrolysis kinetics on liposomal release of topotecan.

Authors:  Kyle D Fugit; Bradley D Anderson
Journal:  J Control Release       Date:  2013-11-12       Impact factor: 9.776

5.  Effect of cyclodextrin complexation on the liposome permeability of a model hydrophobic weak Acid.

Authors:  Vijay Joguparthi; Bradley D Anderson
Journal:  Pharm Res       Date:  2008-07-19       Impact factor: 4.200

6.  Dynamic, nonsink method for the simultaneous determination of drug permeability and binding coefficients in liposomes.

Authors:  Kyle D Fugit; Bradley D Anderson
Journal:  Mol Pharm       Date:  2014-03-28       Impact factor: 4.939

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.